- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    j_codes:
    - J1595
    - J1745
    - J2350
    ndc:
    - 0078-0429
    - 0078-0518
    - 50419-488
  conditions:
    any_of:
    - dx_in_value_set: vs_relapsing_remitting_ms_2025_09
    - dx_in_value_set: vs_secondary_progressive_ms_2025_09
    all_of:
    - age_gte: 18
    - has_flag: confirmed_ms_diagnosis
    - has_flag: specialist_evaluation
    - has_flag: mri_evidence_activity
    none_of:
    - has_flag: primary_progressive_ms
    - has_flag: severe_immunosuppression
  logic:
    outcome: PA_REQUIRED
    note: Disease-modifying therapies for relapsing forms of multiple sclerosis
  precedence: 90
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_neurology_ms_2025.pdf
    last_verified_at: '2025-09-11'
    last_updated: '2025-09-11'
  id: rule_99f454e99b20
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    j_codes:
    - J1300
    - J2323
    ndc:
    - 0078-0659
    - 50419-531
  conditions:
    any_of:
    - dx_in_value_set: vs_highly_active_ms_2025_09
    - dx_in_value_set: vs_rapidly_evolving_severe_ms_2025_09
    all_of:
    - age_gte: 18
    - has_flag: failed_first_line_dmt
    - has_flag: high_disease_activity
    - has_flag: specialist_evaluation
    none_of:
    - has_flag: active_infection
    - has_flag: malignancy_history
  logic:
    outcome: PA_REQUIRED
    note: High-efficacy DMTs for highly active or rapidly evolving severe MS
  precedence: 95
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_neurology_ms_2025.pdf
    last_verified_at: '2025-09-11'
    last_updated: '2025-09-11'
  id: rule_8923c4ba4433
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '70551'
    - '70552'
    - '70553'
    hcpcs:
    - A9579
    - A9576
  conditions:
    any_of:
    - dx_in_value_set: vs_multiple_sclerosis_2025_09
    - dx_in_value_set: vs_ms_monitoring_2025_09
    all_of:
    - age_gte: 18
    - has_flag: established_ms_diagnosis
    - has_flag: specialist_evaluation
    none_of:
    - has_flag: mri_within_6_months
  logic:
    outcome: PA_REQUIRED
    note: Brain MRI with gadolinium for MS monitoring and disease activity assessment
  precedence: 80
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_neurology_ms_2025.pdf
    last_verified_at: '2025-09-11'
    last_updated: '2025-09-11'
  id: rule_ea7d3d77ffa7
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    j_codes:
    - J1100
    - J2001
    cpt:
    - '96365'
    - '96366'
  conditions:
    any_of:
    - dx_in_value_set: vs_ms_relapse_2025_09
    - dx_in_value_set: vs_acute_ms_exacerbation_2025_09
    all_of:
    - age_gte: 18
    - has_flag: confirmed_ms_relapse
    - has_flag: functional_impairment
    - has_flag: specialist_evaluation
    none_of:
    - has_flag: steroid_contraindication
    - has_flag: active_infection
  logic:
    outcome: PA_REQUIRED
    note: High-dose corticosteroids for acute MS relapses with functional impairment
  precedence: 85
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_neurology_ms_2025.pdf
    last_verified_at: '2025-09-11'
    last_updated: '2025-09-11'
  id: rule_01ab657ed45f
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '36514'
    - '36516'
    j_codes:
    - J7799
  conditions:
    any_of:
    - dx_in_value_set: vs_severe_ms_relapse_2025_09
    - dx_in_value_set: vs_steroid_refractory_ms_2025_09
    all_of:
    - age_gte: 18
    - has_flag: failed_high_dose_steroids
    - has_flag: severe_functional_decline
    - has_flag: specialist_evaluation
    none_of:
    - has_flag: cardiovascular_instability
    - has_flag: active_infection
  logic:
    outcome: PA_REQUIRED
    note: Plasma exchange for severe steroid-refractory MS relapses
  precedence: 95
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_neurology_ms_2025.pdf
    last_verified_at: '2025-09-11'
    last_updated: '2025-09-11'
  id: rule_84fe5a32d2aa
